Mackenzie Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.5K | Hold |
10,460
| – | – | ﹤0.01% | 1685 |
|
|
2025
Q1 | $15.4K | Hold |
10,460
| – | – | ﹤0.01% | 1648 |
|
|
2024
Q4 | $46.3K | Hold |
10,460
| – | – | ﹤0.01% | 1662 |
|
|
2024
Q3 | $43.1K | Hold |
10,460
| – | – | ﹤0.01% | 1543 |
|
|
2024
Q2 | $68.2K | Hold |
10,460
| – | – | ﹤0.01% | 1466 |
|
|
2024
Q1 | $91.1K | Hold |
10,460
| – | – | ﹤0.01% | 1427 |
|
|
2023
Q4 | $120K | Sell |
10,460
-2,253
| -18% | -$25.8K | ﹤0.01% | 1389 |
|
|
2023
Q3 | $123K | Buy |
12,713
+2,253
| +22% | +$21.9K | ﹤0.01% | 1330 |
|
|
2023
Q2 | $109K | Hold |
10,460
| – | – | ﹤0.01% | 1402 |
|
|
2023
Q1 | $110K | Hold |
10,460
| – | – | ﹤0.01% | 1399 |
|
|
2022
Q4 | $130K | Buy |
+10,460
| New | +$130K | ﹤0.01% | 1299 |
|
|
2021
Q1 | – | Sell |
-45,622
| Closed | -$520K | – | 1160 |
|
|
2020
Q4 | $520K | Sell |
45,622
-48,694
| -52% | -$555K | ﹤0.01% | 830 |
|
|
2020
Q3 | $848K | Buy |
94,316
+21,550
| +30% | +$194K | ﹤0.01% | 698 |
|
|
2020
Q2 | $751K | Sell |
72,766
-344
| -0.5% | -$3.55K | ﹤0.01% | 728 |
|
|
2020
Q1 | $738K | Buy |
73,110
+18,570
| +34% | +$187K | ﹤0.01% | 721 |
|
|
2019
Q4 | $726K | Buy |
+54,540
| New | +$726K | ﹤0.01% | 790 |
|
|
2014
Q2 | – | Sell |
-109,038
| Closed | -$1.13M | – | 643 |
|
|
2014
Q1 | $1.13M | Buy |
109,038
+56,878
| +109% | +$587K | 0.01% | 469 |
|
|
2013
Q4 | $507K | Hold |
52,160
| – | – | ﹤0.01% | 574 |
|
|
2013
Q3 | $517K | Buy |
52,160
+238
| +0.5% | +$2.36K | ﹤0.01% | 560 |
|
|
2013
Q2 | $432K | Buy |
+51,922
| New | +$432K | ﹤0.01% | 588 |
|